Carillon Tower Advisers’s Labcorp LH Stock Holding History

Carillon Tower Advisers’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$2.2M	Sell	12,571 -582	-4%	-$101K	0.01%	461
2020 Q3	$2.13M	Sell	13,153 -1,164	-8%	-$184K	0.03%	411
2020 Q2	$2.04M	Sell	14,317 -815	-5%	-$113K	0.02%	445
2020 Q1	$1.64M	Sell	15,132 -2,095	-12%	-$302K	0.02%	420
2019 Q4	$2.5M	Sell	17,227 -1,397	-8%	-$202K	0.02%	448
2019 Q3	$2.69M	Buy	18,624 +3,725	+25%	+$544K	0.02%	446
2019 Q2	$2.21M	Buy	+14,899	New	+$2.08M	0.02%	456
2018 Q3	–	Sell	-36,550	Closed	-$5.64M	–	451
2018 Q2	$5.64M	Sell	36,550 -8,142	-18%	-$1.23M	0.04%	371
2018 Q1	$6.16M	Hold	44,692	–	–	0.05%	352
2017 Q4	$6.12M	Buy	+44,692	New	+$5.91M	0.07%	217

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Carillon Tower Advisers's LH Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Labcorp (LH) stake by 4.4% in Q4 2020, selling an estimated $101K and leaving 12,571 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #461.

Carillon Tower Advisers first reported a position in LH in Q4 2017 and has held it in 10 quarters since. The position peaked at $6.16M in Q1 2018. 907 funds tracked by Wall St. Rank hold LH as of Q4 2020.

Carillon Tower Advisers held 12,571 shares of Labcorp worth $2.2M as of Q4 2020.
Carillon Tower Advisers sold 582 Labcorp shares in Q4 2020, an estimated $101K.
Labcorp made up 0.01% of Carillon Tower Advisers's portfolio in Q4 2020, its #461 holding.
Carillon Tower Advisers first reported a position in Labcorp in Q4 2017 and has held it in 10 quarters since.
Carillon Tower Advisers's Labcorp position peaked at $6.16M in Q1 2018.
907 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.